Alzamend Neuro enters ATM offering for up to $6.5M in common stock

Alzamend Neuro, Inc.

Entered ATM Sales Agreement with Ascendiant Capital Markets for up to $6.5M of common stock.
Shares sold from time to time at market prices; agent receives customary commission.
Prospectus supplement filed Oct 3, 2024; relies on shelf registration statement 333-273610.
ATM offering provides additional capital but dilutes existing shareholders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.